FDA Investigator Karen G Hirshfield
Karen G Hirshfield has conducted inspections on 34 sites in 1 countries as of 13 Jul 2001. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
34
Last Inspection Date:
13 Jul 2001
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Karen G Hirshfield:
Alan P Kurtzberg,
Angela E Glenn,
Anita Narula, PhD,
Anthony J Lagreca,
Betty Kay Baxter,
Bill Tacket, Jr,
Bryce A Hammer,
Carol S Davis,
CDR Ileana Barreto Pettit,
Chani Broner, PhD,
Cheryl A Clausen,
Cynthia Jim, CSO,
Daniel J Lahar,
Daryl A Dewoskin,
Denise M Digiulio,
Dianna D Wardlow Dotter,
Dillard H Woody, Jr,
Edith M Gonzalez,
Elisa J Beard,
Eric S Myskowski,
Erika V Butler,
Ernest A Clausnitzer,
Esther C Broner, PhD,
Geraldine D Sanders,
Gerard T Schneider,
Gerardo Z Vazquez,
Ginger M Sykes,
Glenn S Quintanilla,
Grace E Mcnally,
Gretchen M Laws,
Gwyn G Dickinson,
Haroon Vohra (NMI),
Isabel Y Espinosa,
James D Romero,
Jamie L Dion,
Jason P Aun,
Jean A Peeples,
Jennifer A Robinson,
Jennifer D Hollstrom,
Jennifer L Huntington,
Joanne E King,
Jolanna A Norton,
Justin R Carr,
Katherine Szestypalow,
Kent C Faul,
Kevin T Gerrity,
Kimberley A Hoefen,
Latorie S Jones,
LCDR Michael H Tollon,
Leo J Lagrotte,
Leslie A Cartmill,
Leslie A Jackanicz,
Linda F Murphy,
Linda K Matheny,
Linda M Cheny,
Lisa Sg Shelton,
Mabany Lizardi,
Marc Balzarini,
Marie B Buen Bigornia,
Mariza M Jafary,
Marlene G Swider,
Matthew J Hansen,
Matthew R Dionne,
Megan K Otero,
Melanie G Warzala,
Michael A Charles,
Michael E Maselli,
Michael J Kuchta,
Michael R Goga,
Michael S Araneta,
Mizanne E Lewis,
Nalini D Lebzelter,
Nancy G Schmidt,
Nathan M Jornod,
Nayan J Patel,
Nicole E Knowlton,
Omotunde O Osunsanmi,
Pablo Alcantara,
Patricia A Brown,
Patricia A Cortez,
Paul L Figarole, Jr,
Prabhu P Raju,
Ramesh Sood,
Robert C Coleman,
Roger F Zabinski,
Roger L Farmer,
Ronald T Weber,
Rose Xu,
Salvatore N Randazzo,
Santiago Gallardo Johnson,
Shari H Shambaugh,
Sidney B Priesmeyer,
Steve Y Rhieu, PhD,
Tamara L Setzer,
Tara L Breckenridge,
Tara L Greene,
Thai T Duong,
Theressa B Smith,
Tracy L Reed,
Tracy M Portelli,
Virginia L Meeks,
Wendy G Tan, PhD,
Zachary A Bogorad,
Zachary L Miller,
Zachary L Stamm,
Zakaria Wahba,
Zhong Li, PhD
Karen G Hirshfield's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2000 | EIR | JMI Daniels Pharmaceuticals, Inc - EIR, 2000-01-21 |
December, 2000 | FDA 483 Response | OSO BioPharmaceuticals Manufacturing, LLC - Form 483R, 2001-01-11 |
May, 2000 | FDA 483 | Nuclear Medicine of Central Florida, Inc - Form 483, 2000-05-11 |
July, 2001 | FDA 483 | Syncor Pharmaceuticals, Inc. - Form 483, 2001-07-23 |
March, 2000 | EIR | Jeffrey R. Levenson, M.D. - EIR, 2000-03-01 |
March, 2000 | FDA 483 | Jeffrey R. Levenson, M.D. - Form 483, 2000-03-01 |
June, 2000 | EIR | Bausch & Lomb Incorporated - EIR, 2000-06-14 |
January, 2000 | FDA 483 | JMI Daniels Pharmaceuticals, Inc - Form 483, 2000-01-21 |
February, 2001 | FDA 483 | Henry (NMI) Milgrom - Form 483, 2001-02-09 |
December, 2000 | FDA 483 | SP Pharmaceuticals LLC - Form 483, 2000-12-08 |
December, 2000 | EIR | OSO BioPharmaceuticals Manufacturing, LLC - EIR, 2000-12-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more